Last reviewed · How we verify
NCT04866446
Evaluation of The Effects of Personal Protective Equipment During Airway Management
trial testing endotracheal intubation and laringeal mask airway insertion in Personal Protective Equipment in 3 participants. Completed in 7 February 2021.
5 February 2021
Quick facts
| Lead sponsor | Kezban Aydan Okuyucu |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 3 |
| Start date | 5 February 2021 |
| Primary completion | 5 February 2021 |
| Estimated completion | 7 February 2021 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- endotracheal intubation and laringeal mask airway insertion
Conditions studied
- Personal Protective Equipment — all drugs for Personal Protective Equipment →
- Airway Management — all drugs for Airway Management →
Sponsor
Kezban Aydan Okuyucu
Who can join
Eligibility, any sex, with Personal Protective Equipment or Airway Management. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Covid-19 disease has caused a worldwide pandemic. However, it was necessary to reduce the transmission of the disease as much as possible. The highest risk of transmission is airway management. Medical personnel responsible for airway management are at the greatest risk. One of the most important ways to protect anesthetists from contamination is to use PPE. But, it should be considered that there is some disadvantage about using PPE. The investigators aimed to evaluate the effects of the use of personal protective equipment and standard uniform during airway management.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04866446
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04866446 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kezban Aydan Okuyucu
- Last refreshed: 29 April 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04866446.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing